Tag Archives: MTNB

Matinas BioPharma Holdings, Inc. (MTNB)

We are a clinical-stage biopharmaceutical company focused on developing
innovative anti-infectives for orphan indications. Our product and development
candidates are derived using our unique and proprietary lipid-crystal
nano-particle, or cochleate, formulation platform delivery technology. Our
proprietary cochleate delivery technology platform, licensed from Rutgers

News about MTNB

Cidara Therapeutics: An Attractive Price For A Niche Opportunity With A High Probability Of Success
Investment Thesis: Cidara Therapeutics is developing a novel echinocandin (CD101) that we believe will compete for first-line treatment of systemic fungal infections in a subset of patients. Current standard of care for patients with invasive candidi...Read More>>>